Cost-effectiveness of intensive exercise therapy directly following hospital discharge in patients with arthritis: Results of a randomized controlled clinical trial

Arthritis Care and Research

Volumn 59, Issue 2, 2008, Pages 247-254

  Bulthuis, Yvette ^a   Mohammad, Sabrina ^b   Braakman Jansen, Louise M A ^a   Drossaers Bakker, K Wiepke ^a   Van De Laar, Martin A F J ^a  

^a UNIVERSITY OF TWENTE   (Netherlands)

^b MEDISCH SPECTRUM TWENTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DISEASE ACTIVITY; DISEASE COURSE; EXERCISE INTENSITY; FEMALE; FOLLOW UP; HEALTH CARE COST; HIP ARTHROPLASTY; HOSPITAL DISCHARGE; HUMAN; KINESIOTHERAPY; KNEE ARTHROPLASTY; MAJOR CLINICAL STUDY; MALE; OSTEOARTHRITIS; OUTCOME ASSESSMENT; PATIENT CARE; PHYSICAL CAPACITY; PHYSIOTHERAPIST; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RANGE OF MOTION; RHEUMATOID ARTHRITIS; TREATMENT DURATION; TREATMENT INDICATION; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ARTHROPLASTY, REPLACEMENT, HIP; ARTHROPLASTY, REPLACEMENT, KNEE; COST-BENEFIT ANALYSIS; EXERCISE THERAPY; FEMALE; FOLLOW-UP STUDIES; HEALTH STATUS; HUMANS; MALE; MIDDLE AGED; OSTEOARTHRITIS, HIP; OSTEOARTHRITIS, KNEE; PATIENT DISCHARGE; QUALITY OF LIFE; TREATMENT OUTCOME;

EID: 39449115338     PISSN: 21514658     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.23332     Document Type: Article

References (34)

1. Convertino VA, Bloomfield SA, Greenleaf JE. An overview of the issues: physiological effects of bed rest and restricted physical activity. Med Sci Sports Exerc 1997;29:187-90.
2. Bulthuis Y, Drossaers-Bakker KW, Taal E, Rasker JJ. Oostveen J, van 't Pad Bosch PJ, et al. Arthritis patients show long-term benefits from 3 weeks intensive exercise training directly following hospital discharge. Rheumatology (Oxford) 2007;40:1712-7.
3. Vliet Vlieland TP, Zwinderman AH, Vandenbroucke JP, Breeveld FC, Hazes JM. A randomized clinical trial of inpatient multidisciplinary treatment versus routine out-patient care in active rheumatoid arthritis. Br J Rheumatol 1996;35:475-82.
4. Van den Ende CH, Breedveld FC, le Cessie S, Dijkmans BA, de Mug AW, Hazes JM. Effect of intensive exercise on patients with active rheumatoid arthritis: a randomised clinical trial. Ann Rheum Dis 2000;59:615-21.
5. De Jong Z, Vliet Vlieland TP. Safety of exercise in patients with rheumatoid arthritis. Curr Opin Rheumatol 2005;17:177-82.
6. Patrick DL, Ramsey SD, Spencer AC, Kinne S, Belza B, Topolski TD. Economic evaluation of aquatic exercise for persons with osteoarthritis. Med Care 2001;39:413-24.
7. Van den Hout WB, do Jong Z, Munneke M, Hazes JM, Breedveld FC, Vliet Vlieland TP. Cost-utility and cost-effectiveness analyses of a long-term, high-intensity exercise program compared with conventional physical therapy in patients with rheumatoid arthritis. Arthritis Rheum 2005;53:39-47.
8. Mitchell C, Walker J, Walters S, Morgan AB, Binns T, Mathers N. Costs and effectiveness of pre- and post-operative home physiotherapy for total knee replacement: randomized controlled trial. J Eval Clin Pract 2005;11:283-92.
9. Thomas KS, Miller P, Doherty M, Muir KR, Jones AC, O'Reilly SC. Cost effectiveness of a two-year home exercise program for the treatment of knee pain. Arthritis Rheum 2005;53:388-94.
10. Richardson G, Hawkins N, McCarthy CJ, Mills PM, Pullen R, Roberts C, et al. Cost-effectiveness of a supplementary class-based exercise program in the treatment of knee osteoarthritis. Int J Technol Assess Health Care 2006;22:84-9.
11. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
12. The Criteria Committee of the New York Heart Association. Nomenclature and criteria for diagnosis of diseases of the heart and great vessels. 9th ed. New York: Little. Brown & Company; 1994. p. 253-6.
13. Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease GOLD Executive Summary. Am J Respir Crit Care Med 2007;176:532-5.
14. Steinbrocker O, Traeger CH, Batterman RC. Therapeutic criteria in rheumatoid arthritis. JAMA 1949;140:659-62.
15. Lorig K, Lubeck D, Kraines RG, Seleznick M, Holman HR. Outcomes of self-help education for patients with arthritis. Arthritis Rheum 1985;28:680-5.
16. Taal E, Rasker JJ, Wiegman O. Patient education and self-management in the rheumatic diseases: a self-efficacy approach [review]. Arthritis Care Res 1996;9:229-38.
17. Drummond MF, O'Brien B, Stoddart GL, Torrance GW. Methods for the economic evaluation of health care programmes. Oxford: Oxford Medical Publications: 1997.
18. Hjelmgren J, Berggren F, Andersson F. Health economic guidelines: similarities, differences and some implications. Value Health 2001;4:225-50.
19. Brazier J, Roberts J, Deverill M. The estimation of a preference-based measure of health from the SK-36. J Health Econ 2002;21:271-92.
20. VanderZee KI, Sanderman R, Heyink JW, de Haes H. Psychometric qualities of the RAND 36-Item Health Survey 1.0: a multidimensional measure of general health status. Int J Behav Med 1996;3:104-22.
21. Fries JF, Spitz P, Kraines RG, Holman HR. Measurement of patient outcome in arthritis. Arthritis Rheum 1980;23:137-45.
22. Siegert CE, Vleming LJ, Vandenbroucke JP, Cats A. Measurement of disability in Dutch rheumatoid arthritis patients. Clin Rheumatol 1984;3:305-9.
23. Tugwell P, Bombardier C, Buchanan WW, Goldsmith CH, Grace E, Hanna B. The MACTAR Patient Preference Disability Questionnaire: an individualized functional priority approach for assessing improvement in physical disability in clinical trials in rheumatoid arthritis. J Rheumatol 1987;14:446-51.
24. Verhoeven AC, Boers M, van der Linden S. Validity of the MACTAR questionnaire as a functional index in a rheumatoid arthritis clinical trial. J Rheumatol 2000;27:2801-9.
25. Vlieland TP, van den Ende CH, Breedveld FC, Hazes JM. Evaluation of joint mobility in rheumatoid arthritis trials: the value of the EPM-range of motion scale. J Rheumatol 1993;20:2010-4.
26. College Voor Zorgverzekeringen (CVZ). Dutch guidelines for pharmacoeconomic research. Amstelveen (The Netherlands): CVZ; 1999. In Dutch.
27. College Voor Zorgverzekeringen (CVZ). Pharmacotherapeutisch kompas 2003. Diemen (The Netherlands): CVZ; 2003.
28. Oostenbrink JB, Koopmanschap MA, Rutten FF. Handleiding voor kosten onderzoek: methoden en richtprijzen voor economische evaluaties in de gezondheidszorg. Diemen (The Netherlands): GVZ; 2004.
29. Koopmanschap MA, Rutten FF. A practical guide for calculating the indirect costs of disease. Pharmacoeconomics 1996;10:460-6.
30. Torrance GW, Feeny DH, Furlong WJ, Barr RD, Zhang Y, Wang Q. Multi-attribute preference functions for a comprehensive health status classification system: Health Utilities Index Mark 2. Med Care 1996;24:702-22.
31. Torrance GW, Feeny D, Furlong W. Visual analog scales: do they have a role in the measurement of preferences for health slates? Med Decis Making 2001;21:329-34.
32. Stucki G, Daltroy L, Katz JN, Johannesson M, Liang MH. Interpretation of change scores in ordinal clinical scales and health status measures: the whole may not equal the sum of the parts. J Clin Epidemiol 1996;49:711-7.
33. Brazier J, Roberts J, Tsuchiya A, Busschbach J. A comparison of the EQ-5D and SF-6D across seven patient groups. Health Econ 2004;13:873-84.
34. Lubeck DP. Patient-reported outcomes and their role in the assessment of rheumatoid arthritis. Pharmacoeconomics 2004;22:27-38.